New Filtration System Selectively Removes Free Hemoglobin and Iron During Extracorporeal Circulation

Researchers have developed a new filtration system designed to selectively remove free hemoglobin, heme, and iron from blood during extracorporeal circulation. The study, published in *Scientific Reports* on July 1, 2026, details a technology engineered to mitigate the physiological damage caused by hemolysis—the rupture of red blood cells—which often occurs during procedures like heart-lung bypass or dialysis.

The filtration system utilizes specialized binding materials to capture toxic byproducts that accumulate in the bloodstream when red blood cells break down. By isolating these components, the device aims to prevent the systemic inflammation and organ damage typically associated with high levels of circulating free hemoglobin and iron. The research team tested the filter’s performance in laboratory settings, measuring its capacity to clear these specific molecules from blood samples while maintaining the integrity of other essential blood components. These findings provide a technical framework for potential future applications in clinical environments where extracorporeal circuits are required.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: July 1, 2026

Author

GOAI